Sichenzia Ross Ference LLP Represents Heyu Biological Technology Corporation in its reverse merger with Hong Chang Global Investment Holdings Limited

Press Release – New York, NY – September 15, 2023 – Sichenzia Ross Ference LLP today announced that it represented Heyu Biological Technology Corporation in a reverse merger with Hong Chang Global Investment Holdings Limited, which through its subsidiary will operate an industrial food park in Fujian, China. Heyu Biological Technology Corporation issued an 80.1% equity stake in exchange for the entire issued capital of Hong Chang Global Investment. The transaction closed on September 4, 2023. The Sichenzia Ross Ference LLP team was led by partner Benjamin Tan and associate Martryn Mak.